Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter ended in March - Earnings Summary

Reviva Pharmaceuticals Holdings

14/05/2024 20:48

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ  reported a
quarterly adjusted loss of 25 cents​​ per share for the quarter
ended in March, higher than the same quarter last year, when the
company reported EPS of -30 cents.  The mean expectation of
three analysts for the quarter was for a loss of 38 cents per
share. Wall Street expected results to range from -46 cents
to -28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Reviva Pharmaceuticals Holdings, Inc.'s reported EPS for
the
quarter was a loss of 25 cents​.
    * The company reported a quarterly loss of $7.43 million.
    * Reviva Pharmaceuticals Holdings, Inc. shares had fallen
by 55.0%
this quarter and lost 67.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 13%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $16.50 
This summary was machine generated from LSEG data May 14 at
07:47 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.38          -0.25          Beat
 Dec. 31 2023      -0.35          -0.35          Met
 Sep. 30 2023      -0.37          -0.44          Missed
 Jun. 30 2023      -0.28          -0.55          Missed